Cleared Traditional

K955356 - ACTIVE ULTRA-SENSITIVE UNCONJUGATED EST...

K955356 is the FDA 510(k) clearance for ACTIVE ULTRA-SENSITIVE UNCONJUGATED EST... by Diagnostic Systems Laboratories, Inc.. It is a Class 1 Chemistry device (product code CGI) cleared through the Traditional 510(k) pathway after a 176-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1996
Decision
176d
Days
Class 1
Risk

K955356 is an FDA 510(k) clearance for the ACTIVE ULTRA-SENSITIVE UNCONJUGATED ESTRIOL. Classified as Radioimmunoassay, Estriol (product code CGI), Class I - General Controls.

Submitted by Diagnostic Systems Laboratories, Inc. (Webster, US). The FDA issued a Cleared decision on May 15, 1996 after a review of 176 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1265 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Diagnostic Systems Laboratories, Inc. devices

Submission Details

510(k) Number K955356 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 21, 1995
Decision Date May 15, 1996
Days to Decision 176 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d slower than avg
Panel avg: 88d · This submission: 176d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CGI Radioimmunoassay, Estriol
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1265
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CGI Radioimmunoassay, Estriol

All 25
Devices cleared under the same product code (CGI) and FDA review panel - the closest regulatory comparables to K955356.
UNCONJUGATED ESTRIOL ASSAY FOR THE BAYER IMMUNO 1 SYSTEM (IN VITRO DIAGNOSTIC SYSTEM)
K974721 · Bayer Corp. · Mar 1998
ACTIVE ULTRASENSITIVE UNCONJUGATED ESTRIOL EIA
K962875 · Diagnostic Systems Laboratories, Inc. · Aug 1996
COAT-A-COUNT FREE ESTRIOL
K932989 · Diagnostic Products Corp. · Dec 1994
AMERLEX-M HIGH SENSITIVITY UNCONJUGATED ESTRIOL
K920576 · Eastman Kodak Company · Mar 1992
MICROZYME UNCONJUGATED ESTRIOL ENZYME IMMUNO KIT
K903359 · Immunotech Corp. · Aug 1990
IMMPULSE FREE ESTRIOL ASSAY REAGENTS
K860900 · Sclavo, Inc. · Apr 1986